IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 11392 
Small font sizeDefault font sizeIncrease font size
Navigate Here
Resource Links
 »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »  Article in PDF (335 KB)
 »  Citation Manager
 »  Access Statistics
 »  Reader Comments
 »  Email Alert *
 »  Add to My List *
* Registration required (free)

In This Article
 »  Abstract
 » Introduction
 » Case Report
 » Discussion
 » Conclusion
 »  References
 »  Article Tables

 Article Access Statistics
    PDF Downloaded169    
    Comments [Add]    
    Cited by others 4    

Recommend this journal


 Table of Contents    
Year : 2012  |  Volume : 44  |  Issue : 2  |  Page : 272-273

Toxic Epidermal Necrolysis induced by rarely implicated drugs

1 Department of Pharmacology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
2 Department of Dermatology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
3 Department of Internal Medicine, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India

Date of Submission08-Nov-2010
Date of Decision24-May-2011
Date of Acceptance26-Dec-2011
Date of Web Publication16-Mar-2012

Correspondence Address:
Nusrat Shafiq
Department of Pharmacology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0253-7613.93871

Rights and Permissions

 » Abstract 

Toxic Epidermal Necrolysis (TEN) and Steven-Johnson Syndrome (SJS) are serious disorders commonly caused as idiosyncratic reactions to drugs, the most common ones being oxicams, anticonvulsants, allopurinol, and sulfonamides. We present a case of TEN in a patient who developed the lesions after ingesting multiple drugs including paracetamol, metoclopramide, antihistamines, and multivitamins. These drugs have rarely been implicated in this disorder. The suspected drugs in this case were paracetamol and metoclopramide. However, the role of other drugs could not be ruled out definitely. The patient was managed with antibiotics, corticosteroids, and parenteral fluids and recovered well.

Keywords: Adverse drug reactions, metoclopromide, paracetamol, Toxic Epidermal Necrolysis

How to cite this article:
Rajagopalan S, Kaur S, Dogra S, Shafiq N, Bhalla A, Pandhi P, Malhotra S. Toxic Epidermal Necrolysis induced by rarely implicated drugs. Indian J Pharmacol 2012;44:272-3

How to cite this URL:
Rajagopalan S, Kaur S, Dogra S, Shafiq N, Bhalla A, Pandhi P, Malhotra S. Toxic Epidermal Necrolysis induced by rarely implicated drugs. Indian J Pharmacol [serial online] 2012 [cited 2023 Oct 3];44:272-3. Available from: https://www.ijp-online.com/text.asp?2012/44/2/272/93871

 » Introduction Top

Toxic epidermal necrolysis (TEN) is a rare life threatening idiosyncratic mucocutaneous drug reaction characterized by widespread epidermal necrosis followed by epidermal detachment. Drugs, infections and immunizations are the most common causes of TEN. Drug-induced TEN is the commonest cause and antiepileptics, antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDS) and allopurinol are the most commonly implicated agents. Here we report a case of TEN which was induced by multiple drugs some of which have been rarely implicated in the causation of TEN.

 » Case Report Top

A 42-year-old woman was referred to medical emergency with extensive epidermal detachment and ocular, genital, and oral lesions of 5 days duration leading to a diagnosis of Toxic Epidermal Necrolysis (TEN). Seven days prior to this admission, she had presented to a general practitioner with symptoms of vertigo, anxiety, and restlessness. Although no provisional or differential diagnosis was found in the documents provided by the patient, she was prescribed antihistamines (cinnarizine and dimenhydrinate), paracetamol/metoclopramide combination and multivitamins. After 8-12 hours, she developed fever, malaise, sore throat, and erythematous maculopapular rash in the perioral region.

She discontinued all medications and was admitted to a general hospital where she was administered piperacillin/tazobactam and dexamethasone. It is unknown whether paracetamol or antihistamines were restarted in the hospital. Her condition deteriorated and she was referred to our hospital. On presentation, she was conscious and afebrile; her heart rate was 110/min and blood pressure was 190/80 mm Hg. Cutaneous examination showed involvement of about 70% total body surface area, with skin necrosis, tenderness, and a positive Nikolsky's sign. There were ulcerations and crusting on oral and genital mucosa. Ocular examination revealed serous discharge along with erosions and crusting of eyelids. She had a history of hypertension and was on some antihypertensive medication (unknown) for a few years. Her hematological and biochemical reports are mentioned in [Table 1].
Table 1: Test reports at three time-points

Click here to view

She was administered intravenous fluids, antihypertensive treatment (amlodipine 5 mg/day), injection hydrocortisone (50 mg IV twice daily), and continued on the same antibiotics. Wound care was given by applying topical antiseptics on eroded areas along with nonadherent dressings. Biochemical reports showed a decrease in blood urea (from 68 mg/dl on admission to 57.6 mg/dl on the second day after admission) and a decrease in serum creatinine (from 1.1 mEq/L on admission to 0.78 mEq/L on the second day after admission) [Table 1]. Parenteral therapy was gradually replaced by oral drugs. On the fourth day, she developed herpetic lesions on the oral mucosa and for that tablet acyclovir was advised thrice a day along with chlorhexidine mouthwash, syrup mucaine gel (antacid), and white petroleum jelly for lips. A Tzanck smear, done on fifth day after admission, failed to show any giant cells or Acantholytic Cells (ACC) [Table 1]. This test was done to rule out pemphigus. The patient showed steady improvement with the therapy given and was discharged, after 8 days, without any sequelae.

 » Discussion Top

This is most likely a case of drug-induced TEN as other causes like upper respiratory tract infection, viral infection, or malignancy were not present. As this was an acute presentation, which occurred right after the drugs were administered, Systemic Lupus Erythematosus (SLE) and rheumatological disorders were ruled out. Pemphigus was ruled out, as the results of the Tzanck smear were negative. TEN was diagnosed from the history and typical clinical features and biopsy was not needed. The prodrome was shorter (8-12 hrs) than the usual 1-3 days. This might have been due to the use of multiple drugs causing an unknown interaction or more likely due to a previous exposure to any or all of these drugs. Causality assessment was done for each of the drugs separately by the method of Kramer et al. [1] Paracetamol and metoclopramide were categorized as probable (score 5) and antihistamines and multivitamins as possible (score 3) causal drugs for this adverse drug reaction. The patient was also on some unknown antihypertensive drug for some years. Since this drug intake was uneventful for a long time, the chances of this medication causing this episode of TEN are minimal.

There have been two case reports [2],[3] of TEN caused by paracetamol and a case control study [4] showing increased risk of SJS or TEN with paracetamol use. Metoclopramide can also cause TEN according to a case report. [5] There have been no case reports of TEN due to a combination of both the drugs, nor have there been any reports regarding TEN being caused by antihistamines or multivitamins. The most likely cause of TEN in this case was paracetamol/metoclopramide. However, the probability of other drugs being responsible could not be ruled out completely. Rechallange was not done as it would be clinically unjustifiable.

 » Conclusion Top

TEN in this patient was probably caused by paracetamol and metoclopramide, but a possibility of an interaction as well as the role of other drugs cannot be ruled out.

 » References Top

1.Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR. An algorithm of Operational assessment of adverse drug reactions. JAMA 1979;242:623-32.  Back to cited text no. 1
2.Bygum A, Gregersen JW, Buus SK. Acetaminophen-induced toxic epidermal necrolysis in a child. Pediatr Dermatol 2004;21:236-8.  Back to cited text no. 2
3.Aalevi A, Ben-Amitai D, Garty BZ. Toxic epidermal necrolysis associated with acetaminophen ingestion. Ann Pharmacother 2000;34:32-4.  Back to cited text no. 3
4.Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-7.  Back to cited text no. 4
5.Metoclopromide: First report of toxic epidermal necrolysis: Case report. React Wkly 2008;1189:25.  Back to cited text no. 5


  [Table 1]

This article has been cited by
1 Whole-Exome Sequencing in Patients Affected by Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Reveals New Variants Potentially Contributing to the Phenotype
Dora Fonseca, Adrien Morel, Kevin Llinas-Caballero, David Bolivar-Salazar, Paul Laissue
Pharmacogenomics and Personalized Medicine. 2021; Volume 14: 287
[Pubmed] | [DOI]
2 Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017
Kazeem Adeola Oshikoya, Ibrahim Abayomi Ogunyinka, Comfort Kunak Ogar, Abiodun Abiola, Ali Ibrahim, Ibrahim Adekunle Oreagba
Therapeutic Advances in Drug Safety. 2020; 11: 2042098620
[Pubmed] | [DOI]
3 Cutaneous adverse drug reactions notified by pharmacovigilance in a tertiary care hospital in north India
Niti Mittal,Mahesh Gupta,Mohit Singla
Cutaneous and Ocular Toxicology. 2014; : 1
[Pubmed] | [DOI]
4 First reports of serious adverse drug reactions in recent weeks
Drugs & Therapy Perspectives. 2012; 28(8): 20
[Pubmed] | [DOI]


Print this article  Email this article


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow